Page 17 - Amrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Amrx Today - Breaking & Trending Today
Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided EPS guidance of $0.800-$0.850 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.900. The company issued revenue guidance of $2.15 billion-$2.25 billion, compared to the consensus revenue estimate of $2.17 billion. Amneal Pharmaceuticals stock […] ....
Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided earnings per share guidance of $0.800-$0.850 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.900. The company issued revenue guidance of $2.15 billion-$2.25 billion, compared to the consensus revenue estimate of $2.17 […] ....
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) traded down 8.1% during trading on Wednesday following a weaker than expected earnings announcement. The stock traded as low as $4.05 and last traded at $4.09. 2,359 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 491,801 shares. The stock had […] ....
Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided EPS guidance of $0.800-$0.850 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.900. The company issued revenue guidance of $2.15 billion-$2.25 billion, compared to the consensus revenue estimate of $2.17 billion.Amneal Pharmaceuticals also updated […] ....